Ernexa Therapeutics Inc.
ERNANasdaqCIK 748592HealthcareFiscal year ends Dec 31
Reports and events: 422 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2022-08-1116:16 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001140361-22-029251 |
| 2022-08-0516:32 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-22-028392 |
| 2022-07-2716:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-22-027135 |
| 2022-07-0116:30 ET | 8-K | 3.01 Delisting notice | 0001140361-22-024797 |
| 2022-07-0121:29 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001140361-22-024669 |
| 2022-07-0121:28 ET | 10-K/A | Annual report, amendedPeriod 2021-12-31 | 0001140361-22-024668 |
| 2022-06-1717:21 ET | 8-K | 3.01 Delisting notice; 4.02 Non-reliance on financial statements; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-22-023519 |
| 2022-06-0716:45 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-22-022218 |
| 2022-05-3107:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-22-021148 |
| 2022-05-2716:35 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-22-021033 |
| 2022-04-2617:00 ET | DEF 14A | Proxy statementPeriod 2022-06-07 | 0001140361-22-015988 |
| 2022-04-1916:30 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001140361-22-015034 |
| 2022-04-1517:18 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-22-014768 |
| 2022-04-1517:07 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001140361-22-014764 |
| 2022-03-1616:30 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-22-009784 |
| 2022-03-0916:21 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-22-008622 |
| 2022-01-2417:00 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001140361-22-002499 |
| 2022-01-2007:40 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-22-002104 |
| 2022-01-0506:06 ET | 8-K | 2.05 Exit or disposal costs | 0001140361-22-000588 |
| 2021-12-2116:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-21-042603 |
| 2021-11-2308:00 ET | 8-K | 8.01 Other events | 0001140361-21-039055 |
| 2021-11-2306:06 ET | S-1/A | Registration statement, amended | 0001140361-21-039018 |
| 2021-11-1817:11 ET | S-1 | Registration statement | 0001140361-21-038586 |
| 2021-11-1216:55 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001140361-21-037674 |
| 2021-11-1206:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-21-037501 |
| 2021-10-1416:26 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-21-034543 |
| 2021-10-0116:31 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001140361-21-033284 |
| 2021-09-2316:30 ET | 8-K | 4.01 Change of auditor; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-21-032255 |
| 2021-09-2016:29 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-21-031830 |
| 2021-09-1407:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-21-031134 |
| 2021-09-1306:05 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-21-030987 |
| 2021-09-0906:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-21-030721 |
| 2021-08-2016:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-21-029038 |
| 2021-08-1717:29 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-21-028700 |
| 2021-08-1317:16 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001140361-21-028301 |
| 2021-07-1917:29 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-21-024792 |
| 2021-07-1916:05 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-21-024732 |
| 2021-07-0117:16 ET | DEF 14A | Proxy statementPeriod 2021-08-20 | 0001140361-21-023197 |
| 2021-06-2117:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-21-021741 |
| 2021-06-1417:00 ET | 8-K | 8.01 Other events | 0001140361-21-020816 |
| 2021-06-1017:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-21-020543 |
| 2021-05-2717:20 ET | S-1 | Registration statement | 0001140361-21-019087 |
| 2021-05-2617:20 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-21-018871 |
| 2021-05-1716:06 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001140361-21-017648 |
| 2021-05-1317:00 ET | SC 13D | Ownership report, active investor | 0001140361-21-017257 |
| 2021-05-1117:25 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-21-016863 |
| 2021-04-3017:16 ET | S-1 | Registration statement | 0001140361-21-015372 |
| 2021-04-3017:11 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001140361-21-015352 |
| 2021-04-3016:11 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001140361-21-015275 |
| 2021-04-2317:20 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001140361-21-014148 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 17:52 ET. Listed shows no prices and gives no investment advice.